Welcome to our dedicated page for Ametek SEC filings (Ticker: AME), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The AMETEK, Inc. (NYSE: AME) SEC filings page provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. AMETEK’s common stock is registered under Section 12(b) of the Securities Exchange Act of 1934 and is listed on the New York Stock Exchange under the trading symbol AME, as confirmed in multiple Form 8-K reports.
Among the key filings available are Form 8-K current reports, which AMETEK uses to announce material events. Recent examples include 8-K filings reporting quarterly financial results under Item 2.02, where the company furnishes press releases detailing net sales, operating income, segment performance for the Electronic Instruments Group and Electromechanical Group, and reconciliations of GAAP to non-GAAP measures such as adjusted operating income and adjusted diluted earnings per share. Other 8-K filings disclose events under Item 5.02, such as the planned retirement of a senior vice president and principal accounting officer and the election of a successor, and under Item 8.01 for events like the completion of the FARO Technologies acquisition.
Filings also include a Form 15 relating to the termination or suspension of reporting obligations for plan interests in the Superior Tube Company, Inc. Union 401(k) Plan following its merger into the AMETEK Retirement and Savings Plan. This document clarifies that AMETEK, Inc. common stock remains a class of securities for which reporting duties continue.
On Stock Titan, AME filings are updated as they are released on EDGAR, and AI-powered summaries can help explain the context and key points in lengthy documents. Users can review current reports for earnings announcements, management changes, and acquisition completions, as well as specialized filings like Form 15 related to benefit plans. This page supports investors who want to understand how AMETEK communicates financial performance, governance changes, and corporate actions through its official SEC reporting.
AMETEK, Inc. has filed a notice that an employee plans to sell 14,310 shares of its common stock on or about 12/15/2025 on the NYSE through Charles Schwab. The filing reports an aggregate market value for the planned sale of $2,892,238 based on the market data used in the form.
The shares were acquired the same day through an employee stock option exercise structured as a broker-facilitated cashless exercise. The form indicates that 230,203,873 shares of AMETEK common stock are outstanding, so the planned sale represents a small portion of the company’s equity base. The seller also represents that they are not aware of any material adverse information about AMETEK’s current or prospective operations that has not been publicly disclosed.
AMETEK Inc. chief executive officer and director David A. Zapico reported gifts and a trust sale of company stock. On 12/12/2025, he made a gift of 3,514 shares of AMETEK common stock and a separate gift of 28,390 shares to a family trust. Following these gifts, he directly held 317,051 shares of AMETEK stock.
The family trust, for which Zapico disclaims beneficial ownership, then sold 28,390 shares of AMETEK common stock on the same date at an average price of $201.76 per share, with individual trades ranging from $201.12 to $202.00. After this transaction, the trust held no AMETEK shares, while Zapico continued to report substantial direct ownership.
AMETEK insider plans to sell 28,390 common shares under Rule 144. The shares are to be sold on the NYSE through Morgan Stanley Smith Barney LLC, with an aggregate market value of $5,727,682.51. AMETEK had 230,203,873 common shares outstanding, and the planned sale date is listed as 12/12/2025.
The securities to be sold were acquired on 06/04/2001 through the exercise of stock options under a registered plan, in two blocks of 16,219 and 12,171 shares paid in cash. Over the past three months, Dave Zapico reported selling 88,000 AMETEK shares on 11/26/2025 for gross proceeds of $17,300,000.00. The signer represents that they are not aware of undisclosed material adverse information about AMETEK’s current or prospective operations.
AMETEK, Inc. (AME) reported an insider transaction by its Chief Executive Officer and director. On 11/25/2025, the reporting person exercised 88,000 stock options at an exercise price of $63.37 per share, acquiring the same number of AMETEK common shares.
On the same date, the insider sold an aggregate of 88,000 common shares in three transactions: 7,432 shares at a weighted average price of $194.89, 25,815 shares at $195.82, and 54,753 shares at $196.86, with detailed price ranges provided in the notes. After these transactions, the insider directly owned 348,955 shares of common stock, plus 23,982 common stock/ SERP units and 11,080 stock options.
AMETEK, Inc. (AME)88,000 shares of its common stock. The shares are to be sold through Charles Schwab & Co., Inc. on the NYSE, with an approximate sale date of 11/25/2025 and an indicated aggregate market value of $17,282,126.00.
The securities were acquired on 11/25/2025 via an employee stock option exercise using a broker payment for a cashless exercise. As context, the table lists 230,203,873 shares of AMETEK common stock outstanding. This filing is a notice of a proposed sale under Rule 144 rather than an issuer offering.
AMETEK, Inc. (AME) disclosed an insider transaction by its Chief Commercial Officer. On 11/12/2025, the officer sold 2,700 shares of common stock at a price of $200 per share, coded “S” for sale.
Following the transaction, the officer beneficially owned 28,293 shares, reported as direct ownership. No derivative securities were listed in the filing.
AMETEK, Inc. (AME) received a Form 144 notice for a proposed sale of 2,700 common shares. The filing lists an aggregate market value of 540000.00 and names Charles Schwab & Co., Inc. as broker. The shares are slated for sale on or about 11/12/2025 on the NYSE.
The securities were acquired on 02/15/2024 through PSU/RSU equity compensation from AMETEK, Inc., in the same amount of 2,700 shares. As context, AMETEK reported 230203873 shares outstanding in the notice.
AMETEK, Inc. (AME) announced leadership changes in its finance organization. Thomas M. Montgomery, Senior Vice President, Comptroller and Principal Accounting Officer, intends to retire effective January 1, 2026, and will remain a Senior Advisor through 2026. The company elected Robert J. Amodei
AMETEK (AME) insider transaction: The company’s Chief Administrative Officer reported option exercises and an open‑market sale on 10/31/2025. He exercised 14,310 options at $63.37 and 11,980 options at $85.45, then sold 26,290 shares at an average price of $200.0459, per the filing.
Following these transactions, beneficial ownership stood at 40,226 shares held directly, 910 shares held indirectly via a 401(k) plan, and 4,865 shares shown as direct under a SERP-related line item. The sale price range was $200.00 to $200.19, with details available upon request.
AMETEK (AME) filed a Form 144 notice for a proposed sale of 26,290 shares of common stock. The filing lists an aggregate market value of $5,259,208.00, with sales expected around 10/31/2025 on the NYSE. The designated broker is Charles Schwab & Co., Inc.
The shares were acquired via an employee stock option exercise on 10/31/2025 through a broker payment for cashless exercise. Shares outstanding were 230,203,873. Form 144 is a notice of intent under Rule 144 and does not itself constitute a registration or sale.